Skip to main content
. 2021 Aug 20;12:700031. doi: 10.3389/fimmu.2021.700031

Figure 4.

Figure 4

Dot Plots showing levels of IGFBP7, SST and IGF2 in serum and CSF samples of MS and controls. (A) IGFBP7 measurements in the serum and CSF of patients with MS and controls. (B) SST measurements in the serum and CSF of patients with MS and controls. (C) IGF2 measurements in the serum and CSF of patients with MS and controls. For simplicity, only significant differences are shown. Statistical significance was defined as ***P < 0.001.